Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Giovarelli

Showing results (71-80 of 113) with videos related to

Pageof 12
Sort By:
Leukemia|July 24, 2009
IL-6, but not IFN-gamma, triggers apoptosis and inhibits in vivo growth of human malignant T cells on STAT3 silencingG Regis, L Icardi, L Conti, et al.
Progress in Clinical and Biological Research|January 1, 1989
Interferon-gamma in the treatment of superficial and recurrent bladder carcinoma. Phase one studyG Fontana, P Caccia, F Alladio, et al.
Immunology Today|January 1, 1997
Cytokines, tumour-cell death and immunogenicity: a question of choiceP Musiani, A Modesti, M Giovarelli, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 1, 1990
Infiltrating leukocyte populations and T-lymphocyte subsets in head and neck squamous cell carcinomas from patients receiving perilymphatic injections of recombinant interleukin 2. A pathologic and immunophenotypic studyG Valente, A De Stefani, C Jemma, et al.
Journal of the National Cancer Institute|August 1, 1985
A novel leukemia T-cell line (PF-382) with phenotypic and functional features of suppressor lymphocytesL Pegoraro, M T Fierro, P Lusso, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1991
Growth and dissemination of human malignant lymphoblasts in immunosuppressed nu/nu miceF Cavallo, C Riccardi, M Forni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1995
5-Fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memoryM Consalvo, C A Mullen, A Modesti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1988
Obligatory role of IFN-gamma in induction of lymphokine-activated and T lymphocyte killer activity, but not in boosting of natural cytotoxicityM Giovarelli, A Santoni, C Jemma, et al.
Cancer|December 15, 1988
Treatment of recurrent squamous cell carcinoma of the head and neck with low doses of interleukin-2 injected perilymphaticallyG Cortesina, A De Stefani, M Giovarelli, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1993
Cytokine-induced tumor immunogenicity: from exogenous cytokines to gene therapyG Forni, M Giovarelli, F Cavallo, et al.
Pageof 12

Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
Leukemia|July 24, 2009
IL-6, but not IFN-gamma, triggers apoptosis and inhibits in vivo growth of human malignant T cells on STAT3 silencingG Regis, L Icardi, L Conti, et al.
Progress in Clinical and Biological Research|January 1, 1989
Interferon-gamma in the treatment of superficial and recurrent bladder carcinoma. Phase one studyG Fontana, P Caccia, F Alladio, et al.
Immunology Today|January 1, 1997
Cytokines, tumour-cell death and immunogenicity: a question of choiceP Musiani, A Modesti, M Giovarelli, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 1, 1990
Infiltrating leukocyte populations and T-lymphocyte subsets in head and neck squamous cell carcinomas from patients receiving perilymphatic injections of recombinant interleukin 2. A pathologic and immunophenotypic studyG Valente, A De Stefani, C Jemma, et al.
Journal of the National Cancer Institute|August 1, 1985
A novel leukemia T-cell line (PF-382) with phenotypic and functional features of suppressor lymphocytesL Pegoraro, M T Fierro, P Lusso, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1991
Growth and dissemination of human malignant lymphoblasts in immunosuppressed nu/nu miceF Cavallo, C Riccardi, M Forni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1995
5-Fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memoryM Consalvo, C A Mullen, A Modesti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1988
Obligatory role of IFN-gamma in induction of lymphokine-activated and T lymphocyte killer activity, but not in boosting of natural cytotoxicityM Giovarelli, A Santoni, C Jemma, et al.
Cancer|December 15, 1988
Treatment of recurrent squamous cell carcinoma of the head and neck with low doses of interleukin-2 injected perilymphaticallyG Cortesina, A De Stefani, M Giovarelli, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1993
Cytokine-induced tumor immunogenicity: from exogenous cytokines to gene therapyG Forni, M Giovarelli, F Cavallo, et al.
Pageof 12